CoChat

Medical Therapy in Peripheral Artery Disease

Open access
Berger, Jeffrey S., Hiatt, William R. · 2012 · Circulation
Cited by 82

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

T he epidemiology of peripheral artery disease (PAD) is well described and related to age and, in particular, the risk factors of diabetes mellitus and smoking.Recent data from the National Health and Nutrition Examination Survey found a 5.9% prevalence in subjects Ն40 years of age resulting in an estimated prevalence of 7.2 million affected individuals in the United States. 1 These subjects have a significant increased risk of all-cause mortality because of the underlying atherosclerotic disease process and general undertreatment of PAD risk factors. 2 There is a wide spectrum of clinical manifestations for PAD: (1) the completely asymptomatic patient found to have PAD from a screening ankle-brachial index (ABI), (2) atypical leg symptoms associated with an exercise limitation, (3) classic intermittent claudication, and (4) ischemic pain and ulceration in the lower extremity from chronic limb ischemia.However, despite the level and degree of limb symptoms, even asymptomatic persons with PAD have a greatly reduced functional capacity.This suggests that occlusive disease in the lower extremity is associated with reduced exercise capacity and functional status regardless of the symptomatic state.As noted above, symptomatic and asymptomatic PAD is associated with an increased risk for morbidity and mortality, and for impairment of quality of life, as well.A prospective cohort in subjects Ͼ65 years of age found a similar high ischemic risk in symptomatic and asymptomatic adults with PAD. 3 Pooled data from 11 studies in 6 countries found that PAD, defined by a an ABI of Ͻ0.90 was associated with an increased risk of subsequent all-cause mortality (relative risk 1.60), cardiovascular mortality (relative risk 1.96), coronary heart disease (relative risk 1.45), and stroke (relative risk 1.35) after adjustment for age, sex, conventional cardiovascular risk factors, and prevalent cardiovascular disease.4 The treatment of PAD has evolved over the past decade to include a broad approach, focusing on the reduction of adverse cardiovascular events, improving symptoms in claudication, and preventing tissue loss in critical limb ischemia.5 Because quality of life is severely limited in these subjects, great emphasis is placed on ameliorating symptoms and reducing the risk of PAD progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.111.033886

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 82

Metadata

Authors
Berger, J. S., & Hiatt, W. R.
Venue
Circulation
Published
2012-07-24
Volume
126
Issue
4
Pages
491-500
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2021473250
Cited by
82
References
15
FWCI
7.22
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.